Aurora Cannabis Inc. closed 29.30% below its 52-week high of $9.35, which the company reached on April 30th.

Aurora Cannabis Inc. (ACB) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is ...

As a leader in the medical cannabis space, Aurora Cannabis is enjoying premium margins. Read why I rate ACB stock a Strong ...

Walmart’s latest brand and logo update has left some social media users baffled. On Jan. 13, the company announced in a press release on its website that it was launching a “comprehensive ...

Medical cannabis company Aurora Cannabis (ACB) has surprised markets with a record-breaking third quarter, sending its shares ...

Jan. 28, 2025 — A new study explores the effects of both recent and lifetime cannabis use on brain function during cognitive tasks. The study, the largest of its kind ever to be completed ...

Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB) –the Canadian based leading global medical cannabis company, is pleased to announce a strategic supply agreement (the ...

Aurora Cannabis has shifted focus to the medical cannabis market, achieving higher gross margins. Read why I upgrade ACB ...

Cannabis stocks Tilray (TLRY) and Canopy Growth (CGC) rallied 7% and 22.2%, respectively, on Wednesday. One of the key drivers of this upside ...

Aurora’s CEO sees consolidation advantage in global medical markets while recreational takes a backseat to international ...

Aurora Cannabis’ short interest ratio sits at 5.2. This tells us that short interest on the stock is relatively high. It also ...